Evaluation of the expression of metalloproteinases 2 and 9 and their tissue inhibitors in colon cancer cells treated with phytic acid

Acta Poloniae Pharmaceutica - Drug Research

Volumn 67, Issue 6, 2010, Pages 625-629

  Kapral, Małgorzata ^a   Wawszczyk, Joanna ^a   Jurzak, Magdalena ^a   Dymitruk, Dominika ^a   Weglarz, Ludmiła ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Colon cancer; Matrix metalloproteinases; mRNA quantification; Phytic acid; Real time QRT PCR

Indexed keywords

GELATINASE A; GELATINASE B; MESSENGER RNA; PHYTIC ACID; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN CACO 2; COLON CANCER; CONTROLLED STUDY; ENZYME KINETICS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REAL TIME POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CACO-2 CELLS; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PHYTIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 78049270997     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Westermarck J., Kahari V.M.: FASEB J. 13, 781 (1999).
2. Egeblad M., Werb Z.: Nat. Rev. Cancer 2, 161 (2002).
3. Folgueras A.R., Pendás A.M., Sánchez L.M., López-Otín C.: Int. J. Dev. Biol. 48, 411 (2004).
4. Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., Goldberg G.I.: J. Biol. Chem. 270, 5331 (1995).
5. Vu T.H., Werb Z: Genes. Dev. 14, 33 (2000).
6. Hidalgo M., Eckhardt S.G.: J. Natl. Cancer. Inst. 93,178 (2001).
7. Kuittinen O.: Acta Univ. Oul. D 712 (2003).
8. Baker A.H., Edwards D.R., Murphy G.: J. Cell Sci.115, 3719 (2002).
9. Schlemmer U., Frřlich W., Prieto R.M., Grases F.: Mol. Nutr. Food Res. 53, S330 (2009).
10. Vucenik I., Shamsuddin A.M.: Nutr. Cancer 55, 109 (2006).
11. Barrientos L.G., Murthy P.P.: Carbohydr. Res. 296, 39 (1996).
12. Cowieson A.J., Acamovic T., Bedford M.R.: Poult. Sci. 85, 878 (2006).
13. Graf E., Eaton J.W.: Free Radic. Biol. Med. 8, 61 (1990).
14. Vucenik I., Shamsuddin A.M.: J. Nutr. 133, 3778S (2003).
15. Verghese M., Rao D.R., Chawan C.B., Walker L.T., Shackelford L.: LWT-Food Sci. Technol. 39, 1093 (2006).
16. Urbano G., López-Jurado M., Aranda P., Vidal-Valverde C., Tenorio E., Porres J.: J. Physiol. Biochem. 56, 283 (2000).
17. Thompson LU, Zhang L.: Carcinogenesis 12, 2041 (1991). .
18. Jenab M., Thompson L. U.: Carcinogenesis 21, 1547 (2000).
19. Tantivejkul K., Vucenik I., Shamsuddin A.M.: Anticancer Res. 23, 3681 (2003).
20. Agarwal C., Dhanalakshmi S., Singh R. P., Agarwal R.: Neoplasia 6, 646 (2004).
21. Vucenik I., Passaniti A., Vitolo M.I., Tantivejkul K., Eggleton P., Shamsuddin A.M.: Carcinogenesis 25, 2115 (2004).
22. Liao J., Seril D.N., Yang A.L., Lu G.G., Yang G.Y.: Carcinogenesis 28, 446 (2007).
23. Schröterová L., Hasková P., Rudolf E., Cervinka M.: Oncol. Rep. 23, 787 (2010).
24. Kermorgant S., Aparicio T., Dessirier V., Lewin M.J.M., Lehy T.: Carcinogenesis 22, 1035 (2001).
25. Li H.W., Shan J.X.: World J. Gastroenterol. 11, 3877 (2005).
26. Gan X Wong B., Wright S.D., Cai T.Q.: J. Interferon Cytokine Res. 21, 93 (2001).
27. Tantivejkul K., Vucenik I., Shamsuddin A. M.: Anticancer Res. 23. 3671 (2003).
28. Kahari V.M., Saarialho-Kere U.: Ann. Med. Feb. 31, 34 (1999).
29. Shamsuddin A.M., Vucenik I., Cole K.E.: Life Sci. 61, 343 (1997).
30. Sakamoto K., Vucenik I., Shamsuddin A.M.: J. Nutr. 123, 713 (1993).
31. Huang C., Ma W.Y., Hecht S.S., Dong Z.: Cancer Res. 57, 2873 (1997).
32. Kapral M., Parfiniewicz B., Strzałka-Mrozik B., Zachacz A., Weglarz L.: Acta Pol. Pharm. Drug Res. 65, 697 (2008).